Flomax for treating enlarged prostate
Flomax is a drug that is given for treating enlarged prostate. The drug belongs to alpha-adrenergic blockers and it acts by relaxing the muscles in the veins and arteries. Hen the muscles are relaxed more blood reaches the region, which gives you relief.
The recommended dosage is only one Flomax capsule a day. It has to be taken with a full glass of water about 30 minutes before food. Unless your doctor has not recommended, do not take Flomax for longer periods and also do not go for larger amounts.
You can take the missed dose when you remember it. But skip the missed one if it is time for your regular dose. If you have stopped taking Flomax for a long period, then you have to contact the doctor who may prescribe a new prescription.
The drug may not be prescribed if you are taking any alpha medicines or if you have allergies to tamsulosin. The doctors do not advice Flomax if you have prostrate cancer.
If you are going to have cataract operation, you should have to tell your surgeon beforehand that you are on Flomax medication. Flomax can affect the pupils during a cataract operation. It is also advised not to perform any hard task after taking Flomax as the drug can cause dizziness. Avoid Alcohol while taking Flomax.
Hives, breathing problems and swelling are some of the allergic reactions noticed with Flomax. Some persons may also come across severe side effects like painful erection that lasts about four hours or more and fainting.
- Learn more about Flomax at www.buyflomax.org
Common prostate growth and Hair growth Drugs That Cause Difficult Situations
There are lots of people showing high interest in taking Flomax or Finasteride on regular basis. These drugs are popularly identified as Proscar and Avodart and these drugs are known to treat the benign prostate enlargement but considerable number is seem to fall apart in reaping maximum benefit. These approved Propecia or Avodart that promise to treat alopecia (the male pattern hair loss) are not without cons. People today are broadly depending on these drugs but they are running at risk of undergoing some of the adverse events.
The journal Endocrine Reviews and Metabolic Disorders has made this information public and their collaborative review is presently online. Abdulmaged Traish who is one of the PhD professors of biochemistry along with urology at (BUSM which is Boston University School of Medicine (BUSM) is the one to guide the entire process. The paper is seen to be summarizing the current existing data also the true impact of these drugs on sexual functionality as well as the cognitive dysfunction, depression and insulin resistance.
Finasteride and Flomax belong to the family of 5α-reductase inhibitors (5α-RIs). They hold back the changing of testosterone to 5α-dihydrotestosterone (5α-DHT) along with some of the other fundamental steroid hormones. When the volume of 5α-DHT reduces in the prostrate, gradually the prostate volume drops off. With such decrease the urinary flow is improved.
Now there are varying controversies regarding the difficulties that 5α-RIs causes but the clinical evidence by far hints at the sexual adverse side of the therapy. Finasteride consumption hints at the libido loss in patients in 10 percent whereas 18 percent is known to suffer from erectile dysfunction. However there are some patients who may become stable right after stopping the treatment. Medical researches however confirm that the first six months of therapy show the sexual side effects and then returning to the baseline is simply erroneous. However Traish is of opinion that the dysfunction mechanism is probable to have many factors, connected to either the straightway reduction in 5α-DHT or it could be having undeviating effect on peripheral as well as central nerves.”
As opposite to sexual side effects, some investigations are conducted whether 5α-RIs can be made use of in preventing the effects of prostate cancer chemo. But researchers have concluded that the data is open to doubt. They think that the chances for cardiovascular side effects of the treatment call for more all inclusive investigation. He also added that 5α-R Inhibition is likely to initiate insulin resistance along with other conditions such as vascular illness, type 2 diabetes plus osteoporosis, nonetheless studies have many doubts and questions. It is seen that the investigation and survey carried out in the case of psychiatric side effects of 5α-RIs is having few notable limitations. However roughly cases are there that pronounce depression and anxiety symptoms in high level among patients.
The U.S. National Institutes of Health focused on post finasteride syndrome (PFS) and choose to integrate the same into their Genetic and Rare Diseases Information Center.
However for the PFS spectrum no particular diagnostic criteria has been indicated. However more studies are needed on PFS in order to decide any association between dosing and the severe adverse effects.
However the authors challenge that such piece of education and demanded alertness of severe side effects of 5α-RIs is required to be spread among patients and clinicians equally. Traish says that one should understand in the first place who will be requiring the medication and who not in order to derive higher benefits. The authors also recommend the further investigation into the side effects that 5α-RIs is needed.